Explore the words cloud of the MEL-PLEX project. It provides you a very rough idea of what is the project "MEL-PLEX" about.
The following table provides information about the project.
Coordinator |
ROYAL COLLEGE OF SURGEONS IN IRELAND
Organization address contact info |
Coordinator Country | Ireland [IE] |
Project website | http://www.melplex.eu |
Total cost | 3˙583˙870 € |
EC max contribution | 3˙583˙870 € (100%) |
Programme |
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers) |
Code Call | H2020-MSCA-ITN-2014 |
Funding Scheme | MSCA-ITN-ETN |
Starting year | 2014 |
Duration (year-month-day) | from 2014-12-01 to 2018-11-30 |
Take a look of project's partnership.
Novel treatment options and associated personalised, patient-tailored therapies need to be explored and developed for highly heterogeneous and chemotherapy resistant cancers, such as malignant melanoma. This can only be achieved by industry-academia collaborations in newly emerging, innovative research disciplines such as translational cancer systems biology and systems medicine. These disciplines and the associated European training needs provide the foundation for the MEL-PLEX ETN. MEL-PLEX aims to understand the network-level and multi-scale regulation of disease-relevant signalling in melanoma through a combination of quantitative biomedical and computational research approaches that go significantly beyond the current state-of-the-art. Coordinated by the RCSI Centre for Systems Medicine, MEL-PLEX will train 15 early stage researchers through a highly interdisciplinary and intersectoral research training programme. MEL-PLEX comprises 11 beneficiaries and 7 partner organisations from 11 countries, including European and international leaders in personalised melanoma therapy, melanoma systems biology and cancer systems medicine. MEL-PLEX aims to (i) achieve an unmatched depth of molecular and mechanistic disease understanding, (ii) will exploit this knowledge to develop and validate predictive models for disease progression, prognosis and responsiveness to current and novel (co-)treatment options, and (iii) will provide superior and clinically relevant tools and biomarker signatures for personalising and optimising melanoma treatment. The MEL-PLEX ETN addresses current needs in academia and the private sector for researchers that have been trained in an environment that spans across biology, medicine and mathematics, that can navigate confidently between clinical, academic and private sector research environments, and that have developed an innovative and creative mindset to progress research findings towards applications.
Dissemination report 3 | Documents, reports | 2019-10-08 17:03:05 |
MEL-PLEX conference | Other | 2019-10-08 17:03:06 |
Final dissemination report | Documents, reports | 2019-10-08 17:03:07 |
Website | Websites, patent fillings, videos etc. | 2019-10-08 16:55:03 |
Dissemination report 2 | Documents, reports | 2019-10-08 16:55:02 |
Dissemination report 1 | Documents, reports | 2019-10-08 16:54:55 |
Take a look to the deliverables list in detail: detailed list of MEL-PLEX deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2018 |
Bruce Moran, Romina Silva, Antoinette S. Perry, William M. Gallagher Epigenetics of malignant melanoma published pages: 80-88, ISSN: 1044-579X, DOI: 10.1016/j.semcancer.2017.10.006 |
Seminars in Cancer Biology 51 | 2019-10-08 |
2018 |
Sébastien De Landtsheer, Philippe Lucarelli, Thomas Sauter Using Regularization to Infer Cell Line Specificity in Logical Network Models of Signaling Pathways published pages: , ISSN: 1664-042X, DOI: 10.3389/fphys.2018.00550 |
Frontiers in Physiology 9 | 2019-10-08 |
2018 |
Erminia Romano, Nicole Rufo, Hannelie Korf, Chantal Mathieu, Abhishek D. Garg, Patrizia Agostinis BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells published pages: , ISSN: 1949-2553, DOI: 10.18632/oncotarget.24815 |
Oncotarget 9/25 | 2019-10-08 |
2018 |
Jan Rožanc, Theodore Sakellaropoulos, Asier Antoranz, Cristiano Guttà , Biswajit Podder, Vesna Vetma, Nicole Rufo, Patrizia Agostinis, Vaia Pliaka, Thomas Sauter, Dagmar Kulms, Markus Rehm, Leonidas G. Alexopoulos Phosphoprotein patterns predict trametinib responsiveness and optimal trametinib sensitisation strategies in melanoma published pages: , ISSN: 1350-9047, DOI: 10.1038/s41418-018-0210-8 |
Cell Death & Differentiation | 2019-10-08 |
2018 |
Kotryna Seip, Kjetil Jørgensen, Marco Vincent Haselager, Marco Albrecht, Mads Haugland Haugen, Eivind Valen Egeland, Philippe Lucarelli, Olav Engebraaten, Thomas Sauter, Gunhild Mari Mælandsmo, Lina Prasmickaite Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment published pages: 1-13, ISSN: 0304-3835, DOI: 10.1016/j.canlet.2018.09.023 |
Cancer Letters 439 | 2019-10-08 |
2017 |
Maddalena Maria Bolognesi, Marco Manzoni, Carla Rossana Scalia, Stefano Zannella, Francesca Maria Bosisio, Mario Faretta, Giorgio Cattoretti Multiplex Staining by Sequential Immunostaining and Antibody Removal on Routine Tissue Sections published pages: 431-444, ISSN: 0022-1554, DOI: 10.1369/0022155417719419 |
Journal of Histochemistry & Cytochemistry 65/8 | 2019-10-08 |
2018 |
Oleksii S. Rukhlenko, Fahimeh Khorsand, Aleksandar Krstic, Jan Rozanc, Leonidas G. Alexopoulos, Nora Rauch, Keesha E. Erickson, William S. Hlavacek, Richard G. Posner, Silvia Gómez-Coca, Edina Rosta, Cheree Fitzgibbon, David Matallanas, Jens Rauch, Walter Kolch, Boris N. Kholodenko Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS Signaling published pages: 161-179.e14, ISSN: 2405-4712, DOI: 10.1016/j.cels.2018.06.002 |
Cell Systems 7/2 | 2019-10-08 |
2018 |
Greta Del Mistro, Philippe Lucarelli, Ines Müller, Sébastien De Landtsheer, Anna Zinoveva, Meike Hutt, Martin Siegemund, Roland E. Kontermann, Stefan Beissert, Thomas Sauter, Dagmar Kulms Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma published pages: , ISSN: 2056-7189, DOI: 10.1038/s41540-018-0075-y |
npj Systems Biology and Applications 4/1 | 2019-10-08 |
2017 |
Nicole Rufo, Abhishek D. Garg, Patrizia Agostinis The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy published pages: , ISSN: 2405-8033, DOI: 10.1016/j.trecan.2017.07.002 |
Trends in Cancer | 2019-10-08 |
2016 |
Francesca M Bosisio, James S Wilmott, Nathalie Volders, Marjorie Mercier, Jasper Wouters, Marguerite Stas, Willeke AM Blokx, Daniela Massi, John F Thompson, Richard A Scolyer, Nicolas van Baren, Joost J van den Oord Plasma cells in primary melanoma. Prognostic significance and possible role of IgA published pages: 347-358, ISSN: 0893-3952, DOI: 10.1038/modpathol.2016.28 |
Modern Pathology 29/4 | 2019-10-08 |
2017 |
Vesna Vetma, Jan Rožanc, Emilie M Charles, Christian T Hellwig, Leonidas G Alexopoulos, Markus Rehm Examining the In-Vitro Efficacy of the IAP Antagonist Birinapant as a Single-Agent or in Combination with Dacarbazine to Induce Melanoma Cell Death published pages: , ISSN: 0965-0407, DOI: 10.3727/096504017X14897145996933 |
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | 2019-10-08 |
2016 |
A D Garg, E Romano, N Rufo, P Agostinis Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation published pages: 938-951, ISSN: 1350-9047, DOI: 10.1038/cdd.2016.5 |
Cell Death and Differentiation 23/6 | 2019-10-08 |
2017 |
Marco Albrecht, Damian Stichel, Benedikt Müller, Ruth Merkle, Carsten Sticht, Norbert Gretz, Ursula Klingmüller, Kai Breuhahn and Franziska Matthäus TTCA: an R package for the identification of differentially expressed genes in time course microarray data published pages: , ISSN: 1471-2105, DOI: 10.1186/s12859-016-1440-8 |
BMC Bioinformatics | 2019-10-08 |
2016 |
Joost J van den Oord; Bosisio, Francesca Maria Immunoplasticity in cutaneous melanoma: beyond pure morphology published pages: , ISSN: 0945-6317, DOI: 10.1007/s00428-016-2058-y |
Virchows Archiv 1 | 2019-10-08 |
2017 |
Bruce Moran, Arman Rahman, Katja Palonen, Fiona T. Lanigan, William M. Gallagher Master Transcriptional Regulators in Cancer: Discovery via Reverse Engineering Approaches and Subsequent Validation published pages: 2186-2190, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-16-1813 |
Cancer Research 77/9 | 2019-10-08 |
2017 |
Sébastien De Landtsheer, Panuwat Trairatphisan, Philippe Lucarelli, Thomas Sauter FALCON: a toolbox for the fast contextualization of logical networks published pages: , ISSN: 1367-4803, DOI: 10.1093/bioinformatics/btx380 |
Bioinformatics | 2019-10-08 |
2015 |
Abhishek D. Garg, Lorenzo Galluzzi, Lionel Apetoh, Thais Baert, Raymond B. Birge, José Manuel Bravo-San Pedro, Karine Breckpot, David Brough, Ricardo Chaurio, Mara Cirone, An Coosemans, Pierre G. Coulie, Dirk De Ruysscher, Luciana Dini, Peter de Witte, Aleksandra M. Dudek-Peric, Alberto Faggioni, Jitka Fucikova, Udo S. Gaipl, Jakub Golab, Marie-Lise Gougeon, Michael R. Hamblin, Akseli Hemminki, M Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2015.00588 |
Frontiers in Immunology 6 | 2019-10-08 |
2016 |
Marco Albrecht, Giuseppe Sciume, Philippe Lucarelli, Thomas Sauter Thermodynamically constrained averaging theory for cancer growth modelling published pages: , ISSN: , DOI: 10.1016/j.ifacol.2016.12.141 |
IFAC Papers Online 49/26 | 2019-10-08 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MEL-PLEX" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MEL-PLEX" are provided by the European Opendata Portal: CORDIS opendata.